Efficacy and Safety of Hydroxyurea as Adjuvant Therapy in Pediatric Patients of Transfusion-Dependent Beta-Thalassemia Major at Zhob, Balochistan

Background Hydroxyurea is being used effectively in sickle cell anemia and thalassemia intermedia. Its role in transfusion-dependent beta-thalassemia major yet needs to be clearly established. This study has been carried out to assess the efficacy and safety of hydroxyurea as adjuvant therapy in ped...

Descripción completa

Detalles Bibliográficos
Autores principales: Akram, Sumera, Khan Khattak, Saeed Akhtar, Khan, Muhammad A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359606/
https://www.ncbi.nlm.nih.gov/pubmed/35959173
http://dx.doi.org/10.7759/cureus.26691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359606/
https://www.ncbi.nlm.nih.gov/pubmed/35959173
http://dx.doi.org/10.7759/cureus.26691

Ejemplares similares